Identification of a novel fusion gene in a pre-B acute lymphobastic leukemia with t(1;19)(q23;p13)

Cancer Science

Volumn 95, Issue 6, 2004, Pages 503-507

  Yuki, Yasuhiro ^a   Imoto, Issei ^a,b   Imaizumi, Masue ^c   Hibi, Shigeyoshi ^d   Kaneko, Yasuhiko ^e   Amagasa, Teruo ^a   Inazawa, Johji ^a,b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^e SAITAMA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; DNA BINDING PROTEIN; E2A PBX1 FUSION PROTEIN; HYBRID PROTEIN; MADS DOMAIN PROTEIN; MEF2D DAZAP1 FUSION PROTEIN; PROTEIN DAZAP1; RNA BINDING PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2A; TRANSCRIPTION FACTOR MEF2D; TRANSCRIPTION FACTOR PBX1; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW CELL; CANCER GROWTH; CELL NUCLEUS; CHIMERA; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION 1; CHROMOSOME TRANSLOCATION 19; CONTROLLED STUDY; FEMALE; FUSION GENE; GENE FREQUENCY; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC IDENTIFICATION; HELA CELL; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; INTRON; LEUKEMIA CELL LINE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRE B LYMPHOCYTE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; DNA-BINDING PROTEINS; FEMALE; HUMANS; LEUKEMIA, B-CELL, ACUTE; LEUKEMIA, PRE-B-CELL; MADS DOMAIN PROTEINS; MYOGENIC REGULATORY FACTORS; RECOMBINANT FUSION PROTEINS; RNA-BINDING PROTEINS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 3042642320     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2004.tb03240.x     Document Type: Article

References (26)

1. Greaves MF, Wiemels J. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer 2003; 3: 639-49.
2. Nourse J, Mellentin JD, Galili N, Wilkinson J, Stanbridge E, Smith SD, Cleary ML. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 1990; 60: 535-45.
3. Hunger SP, Galili N, Carroll AJ, Crist WM, Link MP, Cleary ML. The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias. Blood 1991; 77: 687-93.
4. Izraeli S, Janssen JWG, Haas OA, Harbott J, Brok-Simoni F, Walther JU, Kovar H, Henn T, Ludwig WD, Reiter A, Rechavi G, Bartram CR, Gadner H, Lion T. Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: a comparison between cytogenetic and polymerase chain reaction analyses. Leukemia 1993; 7: 671-8.
5. Troussard X, Rimokh R, Valensi F, Leboeuf D, Fenneteau O, Guitard AM, Manel AM, Schillinger F, Leglise C, Brizard A, Gardais J, Lessard M, Flandrin G, Macintyre E. Heterogeneity of t(1;19)(q23;p13) acute leukemias. Br J Haematol 1995; 89: 516-26.
6. Wlodarska I, Stul M, de Wolf-Peeters C, Verhoef G, Mecucci C, Cassiman JJ, van den Berghe H. t(1;19) without detectable E2A rearrangements in two t(14;18)-positive lymphoma/leukemia cases. Genes Chromosom Cancer 1994; 10: 171-6.
7. Weh HJ, Jonveaux P, Seeger D, Felgner J, Hossfeld DK. t(1;19)(q23;p13) in a case of acute monocytic leukemia. Cancer Genet Cytogenet 1996; 87: 52-4.
8. Yoshinari M, Imaizumi M, Eguchi M, Ogasawara M, Saito T, Suzuki H, Koizumi Y, Cui Y, Sato A, Saisho T, Ichinohasama R, Matsubara Y, Kamada N, Iinuma K. Establishment of a novel cell line (TS-2) of pre-B acute lymphoblastic leukemia with a t(1;19) not involving the E2A gene. Cancer Genet Cytogenet 1998; 101: 95-102.
9. Minegishi M, Tsuchiya S, Minegishi N, Konno T. Establishment of five human malignant non-T lymphoid cell lines and mixed lymphocyte-tumor reaction. Tohoku J Exp Med 1987; 151: 283-92.
10. Ariyama Y, Sakabe T, Shinomiya T, Mori T, Fukuda Y, Inazawa J. Identification of amplified DNA sequences on double minute chromosomes in a leukemic cell line KY821 by means of spectral karyotyping and comparative genomic hybridization. J Hum Genet 1998; 43: 187-90.
11. Imoto I, Yang ZQ, Pimkhaokham A, Tsuda H, Shimada Y, Imamura M, Ohki M, Inazawa J. Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas. Cancer Res 2001; 61: 6629-34.
12. Willis TG, Jadayel DM, Coignet LJ, Abdul-Rauf M, Treleaven JG, Catovsky D, Dyer MJ, Rapid molecular cloning of rearrangements of the IGHJ locus using long-distance inverse polymerase chain reaction. Blood 1997; 90: 2456-64.
13. Imoto I, Yuki Y, Sonoda I, Ito T, Shimada Y, Imamura M, Inazawa J. Identification of ZASC1 encoding a Kruppel-like zinc finger protein as a novel target for 3q26 amplification in esophageal squamous cell carcinomas. Cancer Res 2003; 63: 5691-6.
14. Breitbart RE, Liang CS, Smoot LB, Laheru DA, Mahdavi V, Nadal-Ginard B. A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage. Development 1993; 118: 1095-106.
15. Hobson GM, Krahe R, Garcia E, Siciliano MJ, Funanage VL. Regional chromosomal assignments for four members of the MADS domain transcription enhancer factor 2 (MEF2) gene family to human chromosomes 15q26, 19p12, 5q14, and 1q12-q23. Genomics 1995; 29: 704-11.
16. McKinsey TA, Zhang CL, Olson EN. MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem Sci 2002; 27: 40-7.
17. Yu YT, Breitbart R, Smoot LB, Lee Y, Mahdavi V, Nadal-Ginard B. Human myocyte-specific enhancer factor 2 comprises a group of tissue-related MADS box transcription factors. Genes Dev 1992; 6: 1783-98.
18. Shin HH, Seoh JY, Chung HY, Choi SJ, Hahn MJ, Kang JS, Choi MS, Han TH. Requirement of MEF2D in the induced differentiation of HL60 promyeloid cells. Mol Immunol 1999; 36: 1209-14.
19. Tsui S, Dai T, Roettger S, Schempp W, Salido EC, Yen PH. Identification of two novel proteins that interact with germ-cell-specific RNA-binding proteins DAZ and DAZL1. Genomics 2000; 65: 266-73.
20. Dai T, Vera Y, Salido EC, Yen PH. Characterization of the mouse Dazap1 gene encoding an RNA-binding protein that interacts with infertility factors DAZ and DAZL. BMC Genomics 2001; 2: 6.
21. Vera Y, Dai T, Hikim AF, Lue Y, Salido EC, Swerdloff RS, Yen PH. Deleted in azoospermia associated protein 1 shuttles between nucleus and cytoplasm during normal germ cell maturation. J Androl 2002; 23: 622-8.
22. Bonin G, Scamps C, Turc-Carel C, Lipinski M. Chimeric EWS-FLI1 transcript in a Ewing cell line with a complex t(11;22;14) translocation. Cancer Res 1993; 53: 3655-7.
23. Crozat A, Aman P, Mandahl N, Ron D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 1993; 363: 640-4.
24. Rabbitts TH, Forster A, Larson R, Nathan P. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet 1993; 4: 175-80.
25. Ron D. TLS-CHOP and the role of RNA-binding proteins in oncogenic transformation. Curr Top Microbiol Immunol 1997; 220: 131-42.
26. Mercher T, Busson-Le Coniat M, Monni R, Mauchauffee M, Nguyen Khac F, Gressin L, Mugneret F, Leblanc T, Dastugue N, Olivier AB. Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia. Proc Natl Acad Sci USA 2001; 99: 5776-9.